Team

JPT has a work force of >150 highly trained and skilled employees. 30 of our co-workers hold a university degree and 20 have a PhD in natural sciences. Over the last 15 years our team has built a substantial know-how in all areas of peptide applications ranging from antigen discovery and immune monitoring to proteomics and immunotherapy development.

Aurélien Claeyssen (Managing Director)

Aurélien Claeyssen has been managing director of JPT Peptide Technologies since January 2024. He holds a Masters degree in Biotechnology and Management from the Faculty of Pharmacy of Grenoble and the Grenoble Management School (France). After 3 years as a business developer in life sciences, he co-founded Smartox in 2013, a peptide-based drug discovery company, and SB-PEPTIDE in 2016, a peptide CDMO company. He served as Chief Commercial Officer and Board Member.

Dr. Sierk Poetting (Managing Director)

Dr. Sierk Poetting holds a Master of Science in Optical Sciences from the University of Arizona and a Ph.D. in Physics from the Ludwig-Maximilians-University in Munich.

From 2012 to August 2014 he worked for Novartis and served as Vice President and Chief Financial Officer for the Sandoz Division in North America.

Afterwards he took over the position as Chief Financial Officer and Chief Operating Officer at BioNTech SE.